Evidence map›Paper›PMID 28835862›Full record

ArticleCase reports in pediatrics2017

Late Onset Cobalamin Disorder and Hemolytic Uremic Syndrome: A Rare Cause of Nephrotic Syndrome.

Gianluigi Ardissino, Michela Perrone, Francesca Tel, Sara Testa, Amelia Morrone, Ilaria Possenti, Francesco Tagliaferri, Robertino Dilena, Francesca Menni

Open access · goldAbstract readCase Reports
In one paragraph

Article in Case reports in pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Gianluigi ArdissinoCenter for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.ORCID 0000-0002-0659-1206
Michela PerroneCenter for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Francesca TelCenter for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Sara TestaCenter for HUS Prevention Control and Management, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Amelia MorronePaediatric Neurology Unit and Laboratories, Neuroscience Department, Meyer Children's Hospital, Florence, Italy.
Ilaria PossentiPediatric Unit, Pediatric Hospital C. Arrigo, Alessandria, Italy.ORCID 0000-0002-1407-7805
Francesco TagliaferriPediatric Unit, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Robertino DilenaUOC Neurophysiology, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Francesca MenniPediatric Unit, Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico, Milan, Italy.
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITMeyer Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemolytic uremic syndrome (HUS) is an unrare and severe thrombotic microangiopathy (TMA) caused by several pathogenetic mechanisms among which Shiga toxin-producing

Identifiers

PMID28835862
PMCPMC5557262
OpenAlexW2741193889

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.